Vitamin E supplementation alters HDL-cholesterol concentration and paraoxonase activity in rabbits fed high-cholesterol diet: Comparison with probucol

Journal of Biochemical and Molecular Toxicology

Volumn 19, Issue 5, 2005, Pages 336-346

  Jeon, Seon Min ^a   Park, Yong Bok ^a   Kwon, Oh Shin ^a   Huh, Tae Lin ^a   Lee, Won Ha ^a   Do, Kyung Min ^a   Park, Taesun ^b   Choi, Myung Sook ^a  

^a Kyungpook National University   (South Korea)

^b Yonsei University   (South Korea)

Author keywords

Cholesterol Regulating Enzymes; mRNA Expression; Plasma Lipids; Probucol; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ARYLDIALKYLPHOSPHATASE; CHOLESTEROL; CHOLESTEROL ACYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LIPID; MESSENGER RNA; PROBUCOL; STEROL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CHOLESTEROL METABOLISM; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; FECES ANALYSIS; LIPID BLOOD LEVEL; MALE; NONHUMAN; OXIDATIVE STRESS; RABBIT; VITAMIN SUPPLEMENTATION;

ALANINE TRANSAMINASE; ANIMALS; ANTICHOLESTEREMIC AGENTS; AORTA; ARYLDIALKYLPHOSPHATASE; ASPARTATE AMINOTRANSFERASES; BASE SEQUENCE; BODY WEIGHT; CHOLESTEROL, HDL; DNA PRIMERS; GENE EXPRESSION; LIVER; MALE; PROBUCOL; RABBITS; VITAMIN E;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 27844598343     PISSN: 10956670     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbt.20098     Document Type: Article

References (59)

1. Barbir M, Wile D, Trayner I, Aber VR, Thompson GR. High prevalence of hypertriglyceridemia and apolipoprotein abnormalities in coronary artery disease. Br Heart J 1988;60:397-403.
2. Juhel C, Dubois C, Senft M, Levy E, Lafont H, Lairon D. Postprandial lipeamia is exacerbated in fat-cholesterol-fed rabbits: Relationship to atheroma deposition. Br J Nutr 1997;78:301-311.
3. Ross R, Harker L. Hyperlipidemia and atherosclerosis. Science 1976;193:1094-1100.
4. Small DM, Bond MG, Waugh D, Prack M, Sawyer JK. Physicochemical and histological changes in the arterial wall of non-human primates during progression and regression of atherosclerosis. J Clin Invest 1984;73: 1590-1605.
5. Oram JF. Receptor-mediated transport of cholesterol between cultured cells and high density lipoproteins. Methods Enzymol 1986;129:645-659.
6. Mackness MI, Mackness B, Durrington PN, Fogelman AM, Berliner J, Lusis AJ, Navab M, Shih D, Fonarow GC. Paraoxonase and coronary heart disease. Curr Opin Lipidol 1998;9:319-324.
7. Stocker R, Keaney JF Jr. Role of oxidative modifications in atherosclerosis. Physiol Rev 2004;84(4):1381-1478.
8. McQuillan BM, Hung J, Beilby JP, Nidorf M, Thompson PL. Antioxidant vitamins and the risk of carotid atherosclerosis. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS). J Am Coll Cardiol 2001;38(7):1788-1794.
9. Kita T, Nagano Y, Yokode M, Ishii K, Ooshima A, Yoshida H, Kawai C. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc Natl Acad Sci USA 1987;84:5928-5931.
10. Jialal I, Fuller CJ, Huet BA. The effect of alpha-tocopherol supplementation on LDL oxidation. A dose-response study. Arterioscler Thromb Vasc Biol 1995;15(2):190-198.
11. Allain CC, Poon LS, Chen CSG, Richmond W, Fu P. Enzymatic determination of total serum cholesterol. Clin Chem 1974;20(4):470-175.
12. Fossati P, Prencipe L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 1982;28:2077-2088.
13. Friedbald WT, Levy RI, Fredrickson DA. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
14. Yamajaki K, Murata M. Frequency of athegenic risk factors in Japanese obese children. Diabetes Res Clin Pract 1994;10:S211-S219.
15. Hulcher MW, Oleson WH. Simplified spectrophotometric assay for microsomal 3-hydroxy-3-methylglutaryl CoA reductase by measurement of coenzyme A. J Lipid Res 1973;14:625-631.
16. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
17. Shapiro DJ, Nordstrom JL, Mitschelen JJ, Rodwell VW, Schimke RT. Microassay for 3-hydroxy-3-methylglutaryl CoA reductase in rat liver and in L-cell fibroblast. Biochim Biophys Acta 1974;370:369-377.
18. Gillies PJ, Rathgeb KA, Robinson CS. Regulation of acyl-CoA:cholesterol acyltransferase activity in normal and atherosclerotic rabbit aortas: Role of a cholesterol substrate pool. Exp Mol Pathol 1986;44:320-339.
19. Mackness MI, Arrol S, Durrington PN. Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Lett 1991;286:152-154.
20. Czubayko F, Beumers B, Lutjohann D, von Bergmann K. A simplified micro-method for quantification of fecal excretion of neutral and acidic sterols for outpatient studies in humans. J Lipid Res 1992;32:1861-1867.
21. Michael JC, Ian AM. Enzymatic determination of 3α, 7α-, and 12α-hydroxyl groups of fecal bile salts. Clin Chem 1980;26:1298-1300.
22. Bieri G, Tolliver JJ, Catignan GL. Simultaneous determination of alpha-tocopherol and retinal in plasma or red blood cells by high pressure liquid chromatography. Am J Clin Nutr 1979;32:2143-2149.
23. Reitman S, Frankel S. A colorimetric method for the determination of serum glutamic oxaloacetic and glutamic pyruvvic transaminase. Am J Clin Pathol 1957;2:56-63.
24. Carleton M. Histological techniques, 4th edition. New York: Oxford University Press; 1967. p 166.
25. Kim TG, Jang MK, Jeoung NH, Choi MS, Bok SH, Kwak JW, Park YB. Differentially expressed aortic genes in cholesterol-fed rabbits. Mol Cells 1998;8:324-329.
26. Parker RA, Sabrah T, Cap M, Gill BT. Relation of vascular oxidative stress, α-tocopherol, and hypercholesterolemia to early atherosclerosis in hamsters. Arterioscler Thromb Vasc Biol 1995;15:349-358.
27. Williams RJ, Motteram JM, Sharp CH, Gallagher PJ. Dietary vitamin E and the attenuation of early lesion development in modified Watanabe rabbits. Atherosclerosis 1992;94:153-159.
28. Schwenke DC, Behr SR. Vitamin E combined with selenium inhibits atherosclerosis in hypercholesterolemic rabbits independently of effects on plasma cholesterol concentrations. Circ Res 1998;83:366-377.
29. Torres M, Marquez M, Sutil R, Carrizales M, Leal M, Reigosa A. A study about the effect of vitamin E on hyperlipidemia and atherosclerotic lesions in New Zealand white rabbits fed with a 1% cholesterol rich diet. Invest Clin 2003;44(2):119-127.
30. Monte MJ, Jimenez R. Effects of a hypercholesterolaemia-inducing diet on biliary electrolytes and lipid secretion in the rat. Int J Exp Pathol 1993;74(2):203-210.
31. Ying H, Saku K, Harada R, Takami N, Sasaki N, Saito Y, Arakawa K. Putative mechanisms of action of probucol on high-density lipoprotein apolipoprotein A-I and its isoproteins kinetics in rabbits. Biochim Biophys Acta 1990;1047(3):247-254.
32. Atmeh RF, Stewart JM, Boag DE, Packard CJ, Lorimer AR, Shepherd J. The hypolipidemic action of probucol: A study of its effects on high and low density lipoproteins. J Lipid Res 1983;24(5):588-595.
33. Ismail NM, Abdul Ghafar N, Jaarin K, Khine JH, Top GM. Vitamin E and factors affecting atherosclerosis in rabbits fed a cholesterol-rich diet. Int J Food Sci Nutr 2000;51:S79-S94.
34. Badimon J, Badimon L, Fuster V Regression of atherosclerotic lesions by high-density lipoprotein plasma fraction in the cholesterol-fed rabbits. J Clin Invest 1990;85(4):1234-1241.
35. Miyazaki A, Sakuma S, Morikawa W, Takine T, Miake F, Terano T, Sakai M, Hakamata H, Sakamoto Y, Natio M. Intravenous injection of rabbit apolipoprotein A-I inhibits the progression of atherosclerosis in cholesterol-fed rabbits. Arterioscler Thromb Vasc Biol 1995;15(11): 1882-1888.
36. Shimano H, Yamada N, Katsuki M, Yamamoto K, Gotoda T, Harada K, Shimada M, Yazaki Y. Plasma lipoprotein metabolism in transgenic mice overexpressing apolipoprotein E. Accelerated clearance of lipoproteins containing apolipoprotein B. J Clin Invest 1992;90(5):2084-2091.
37. Zhang SH, Reddick RL, Piedrahita JA, Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science (Washington DC) 1992:258:468-471.
38. Thompson GR, Naoumova RP, Watts GF. Role of cholesterol in regulating apolipoprotein B secretion by the liver. J Lipid Res 1996;37(3):439-447.
39. McConathy WJ, Gesquiere JC, Bass H, Tartar A, Fruchart JC, Wang CS. Inhibition of lipoprotein lipase activity by synthetic peptides of apolipoprotein C-III. J Lipid Res 1992;33(7):995-1003.
40. Fredenrich A, Groux LM, Tremblay M, Krimbow L, Davignon, JS Cohn. Plasma lipoprotein distribution of C-III in normolipidemic and hypertriglyceridemic subjects: Comparison of the apo C-III to apo E ratio in different lipoprotein fractions. J Lipid Res 1997;38:1421-1432.
41. Humphries SE, Talmud PJ, Fischer R. Gene-environment interaction in determining plasma lipids and dietary response.-sponse. In: Pennington Biomedical Research Center, Nutrition, Genetics and Heart Disease. Baton Rough: LSU Press; 1995.
42. Ness GC, Keller RK, Pendleton LC. Feedback regulation of hepatic 3-hydroxy-3-methylglutaryl-CoA reductase activity by dietary cholesterol is not due to altered mRNA levels. J Biol Chem 1991;266(23):14854-14857.
43. Balasubramaniam S, Beins DM, Simons LA. On the mechanism of plasma cholesterol reduction in the rat given probucol. Clin Sci 1981;61(5):615-619.
44. Ou J, Saku K, Jimi S, Ohta T, Zhang B, Pownall HJ, Shimada Y, Tsujita Y, Arakawa K. Mechanism of action of probucol on cholesteryl ester transfer protein (CETP) mRNA in a Chinese hamster ovary cell line that had been stably transfected with a human CETP gene. Biochim Biophys Acta 1998;1393(1):153-160.
45. Carr TP, Parks JS, Rudel LL. Hepatic ACAT activity in African green monkeys is highly correlated to plasma LDL cholesteryl ester enrichment and coronary artery atherosclerosis. Arterioscler Thromb 1992;12(11): 1274-1283.
46. Asami Y, Yamagishi I, Murakami S, Araki H, Tsuchida K, Higuchi S. HL-004, the ACAT inhibitor, prevents the progression of atherosclerosis in cholesterol-fed rabbits. Life Sci 1998;62(12):1055-1063.
47. Largis EE, Wang CH, De Vries VG, Schaffer SA. CL277082: A novel inhibitor of ACAT-catalyzed cholesterol esterification and cholesterol absorption. J Lipid Res 1989;30: 681.
48. Kogushi M, Tanaka H, Ohtsuka I, Yamada T, Kobayashi H, Saeki T, Takada M, Hiyoshi H, Yanagimachi M, Kimura T, Yoshitake S, Saito I. Anti-atherosclerotic effect of E5324, an inhibitor of acyl-CoA:Cholesterol acyltransferase, in Watanabe heritable hyperlipidemic rabbits. Atherosclerosis 1996;124(2):203-210.
49. Blatter MC, James RW, Messmer S, Barja F, Pometta D. Identification of a distinct human high-density lipoprotein subspecies defined by a lipoprotein-associated protein, K-45. Identity of K-45 with paraoxonase. Eur J Biochem 1993;211(3):871-879.
50. Watson AD, Berliner JA, Hama SY, La Du BN, Faull KF, Fogelman AM, Navab M. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. J Clin Invest 1995;96(6):2882-2891.
51. Jarvik GP, Tsai NT, McKinstry LA, Wani R, Brophy VH, Richter RJ, Schellenberg GD, Heagerty PJ, Hatsukami TS, Furlong CE. Vitamin C and E intake is associated with increased paraoxonase activity. Arterioscler Thromb Vasc Biol 2002;22(8):1329-1333.
52. Jeon SM, Lee MK, Park YB, Park HM, Choi MS. Polygonatum Rhizoma affects antioxidant defense systems without changing mRNA expression in diet-induced hypercholesterolemic rabbits. J Med Food 2004;7(3):358-365.
53. Erdincler DS, Seven A, Inci F, Beger T, Candan G. Lipid peroxidation and antioxidant status in experimental animals: Effects of aging and hypercholesterolemic diet. Clin Chim Acta 1997;265(1):77-84.
54. Galacia-Mediavilla V, Villares C, Culebras JM, Bayon JE, Gonzalez-Gallego J. Effects of dietary beta-cyclodextrin in hypercholesterolemic rats. Pharmacol Toxicol 2003;92(2):94-99.
55. Andersson TL, Matz J, Ferns GA, Anggard EE. Vitamin E reverses cholesterol-induced endothelial dysfunction in the rabbit coronary circulation. Atherosclerosis 1994;1111(1):39-45.
56. Donetti E, Soma MR, Barberi L, Paoletti R, Fumagalli R, Roma P, Catapano AL. Dual effects of the antioxidant agents probucol and carvedilol on proliferative and fatty lesions in hypercholesterolemic rabbits. Atherosclerosis 1998;141(1):45-51.
57. Princen HMG, van Poppel G, Vogelezang C, Buytenhek R, Kok FJ. Supplementation with vitamin E but not betacarotene in vivo protects low-density lipoprotein from lipid peroxidation in vitro. Effect of cigarette smoking. Arterioscler Thromb 1992;12:554-562.
58. Boscoboinik D, Szewczyk A, Hensey C, Azzi A. Inhibition of cell proliferation by alpha-tocopherol: Role of protein kinase C. J Biol Chem 1991;266:6188-6194.
59. Steiner M. Vitamin E enhances the benefits of aspirin in preventing or reducing the incidence of strokes. Second-International Congress on Antioxidant Vitamins and Beta-Carotene in Disease Prevention, Berlin, 1994, October 10-12, 22 (abstract).